Realizing the promise.

We are at the cusp of a revolution in medicine. Synthetic biology is an entirely new strategy in drug development, affording us the opportunity to design selective and potent living medicines to treat disease. With a team of experienced scientists and executives at the helm, Synlogic is forging new ground to advance this approach and design novel therapeutics to treat unmet medical needs.

null

Aoife Brennan, MB, BCh, BAO, MRCPI

President and Chief Executive Officer
null

Antoine Awad

Chief Operating Officer
null

Molly Harper

Chief Business Officer
null

DAVID HAVA, PHD

CHIEF SCIENTIFIC OFFICER
null

Michael Jensen

CHIEF FINANCIAL OFFICER
null

Caroline B. Kurtz, PhD

Chief Development Officer
null

Brendan St. Amant

Head of Legal
null

Adam Thomas

Chief People Officer and Secretary